Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 26.43
-0.77 (-2.83%)
Jun 5, 2025, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 8.94 billion as of June 5, 2025. Its market cap has increased by 71.55% in one year.
Market Cap
8.94B
Enterprise Value
8.81B
Revenue
783.21M
Ranking
n/a
PE Ratio
182.78
Stock Price
26.43
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 8.94B, an increase of 5,778.05%. That is a compound annual growth rate of 71.42%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 117.64B |
| Pro Medicus | 29.34B |
| Cochlear | 17.74B |
| Sonic Healthcare | 12.70B |
| Ramsay Health Care | 8.73B |
| Ansell | 4.51B |
| Regis Healthcare | 2.29B |
| Mesoblast | 2.26B |